Our aim is to tailor our oncology portfolio to address the most pressing needs in India
Express Pharma
JUNE 10, 2024
As India is a price-sensitive market and most of healthcare needs are out-of-pocket rather than covered by insurance, what are the market access and affordability strategies that Merck has incorporated to stay ahead in the oncology segment? Have there been substantial improvements in the ease of doing business in India?
Let's personalize your content